From Comm. Of Mass:
Monoclonal antibody therapy (mAb) is a promising option for higher-risk patients who have tested positive for COVID-19 or who have been exposed to someone with COVID-19. Higher-risk patients may be older or have a medical condition. When given in a timely manner, mAb has been shown to be effective in reducing the severity of disease and keeping COVID-19-positive patients out of the hospital.
Sandy also said he took ivermectin.
Maybe it's time to ping all the vaxholes to alert them of this.
Yes, Jeff has Type II. Hope he gets better soon.
“Monoclonal antibody therapy (mAb) is a promising option for higher-risk patients”
mAb’s don’t normally kill people or cause life-altering conditions. Why should it be restricted to high-risk?